References
1. Lawrence, K.R., M. Adra, and P.K. Gillman, Serotonin Toxicity Associated with the Use of Linezolid: A Review of Postmarketing Data. Clinical Infectious Diseases, 2006.42 (11): p. 1578-1583.
2. Moellering, R.C., Linezolid: the first oxazolidinone antimicrobial. Ann Intern Med, 2003.138 (2): p. 135-42.
3. Baldo, B.A., Opioid analgesic drugs and serotonin toxicity (syndrome): mechanisms, animal models, and links to clinical effects. Arch Toxicol, 2018. 92 (8): p. 2457-2473.
4. Quinn, D.K. and T.A. Stern,Linezolid and serotonin syndrome. Primary care companion to the Journal of clinical psychiatry, 2009. 11 (6): p. 353-356.
5. Mitchell, R.S., Fatal toxic encephalitis occurring during iproniazid therapy in pulmonary tuberculosis. Ann Intern Med, 1955. 42 (2): p. 417-24.
6. Bartlett, D., Drug-Induced Serotonin Syndrome. Crit Care Nurse, 2017. 37 (1): p. 49-54.
7. Quinn, D.K. and T.A. Stern,Linezolid and serotonin syndrome. Prim Care Companion J Clin Psychiatry, 2009. 11 (6): p. 353-6.
8. Mastroianni, A. and G. Ravaglia,Serotonin syndrome due to co-administration of linezolid and methadone. Infez Med, 2017. 25 (3): p. 263-266.
9. Dunkley, E.J.C., et al., The Hunter Serotonin Toxicity Criteria: simple and accurate diagnostic decision rules for serotonin toxicity. QJM: An International Journal of Medicine, 2003. 96 (9): p. 635-642.
10. Mason, P.J., V.A. Morris, and T.J. Balcezak, Serotonin syndrome. Presentation of 2 cases and review of the literature. Medicine, 2000. 79 (4): p. 201-209.
11. Mills, K.C., Serotonin syndrome: a clinical update. Critical care clinics, 1997.13 (4): p. 763-783.